-
Forward Look
Ushering in a New Standard of CareTargeted therapy extends progression-free survival in people with stage III EGFR-mutated lung cancer.
by Darcy Lewis
-
Making Their Mark
With targeted therapy options available for a growing number of cancer types, biomarker testing is making a difference for more people with solid cancers.
by Kendall K. Morgan
-
Survivor Profile
A Cause for ConcernMargie Wilson is helping Black women understand their risk for endometrial cancer and teaching them not to ignore the warning signs.
by Taayoo Murray
-
Healthy Habits
Plant PowerPlant-based diets may help people with prostate cancer reduce their risk for disease progression.
by Anne Danahy
-
Forward Look
Cognition and Prostate CancerAndrogen deprivation therapy, a common prostate cancer treatment, may increase cognitive difficulties.
by Joseph Jalkiewicz
-
Rethinking the Role of Radiation
Chest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona
-
Get Involved
Treasure TroveThe Pediatric Oncology Treasure Chest Foundation provides toys and gifts to young cancer patients.
by Thomas Celona
-
Study Highlights Challenges in Pancreatic Cancer Staging
Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.
by Taneia Surles
-
Understanding How High and Low Testosterone Levels Can Treat Prostate Cancer
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
-
Understanding the Federal Rule on Breast Tissue Density Reports
Screening mammography reports will include breast density and an explanation in common language.
by Sandra Gordon
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles